Residual Tumor Volume Post Cytoreduction (Fallopian Tube)

Data Item Details

Parent Schema: Fallopian Tube
NAACCR Item: #3921
NAACCR XML ID: residualTumVolPostCytoreduction

Notes

Note 1 Physician Statement

• Physician statement of residual tumor status after primary cytoreduction surgery can be used to code this data item when no other information is available.

Note 2 Optimal debulking surgery

• Optimal debulking is described as removal of all tumor except for residual nodules that measure no more than 1 centimeter (cm) in maximum diameter.

Note 3 Purpose of surgery

• The surgery to remove as much cancer in the pelvis and/or abdomen as possible, reducing the "bulk" of the cancer, is called "debulking" or "cytoreductive" surgery.

• It is performed when there is widespread evidence of advanced stage of ovarian cancer with obvious spread to other organs outside the ovary, typically in the upper abdomen, intestines, the omentum (the fat pad suspended from the transverse colon like an apron), the diaphragm, or liver.

Note 4 Gross residual tumor

• Gross residual tumor after primary cytoreductive surgery is a prognostic factor that has been demonstrated in large studies. The best prognostic category after surgery includes those who are left with no gross residual tumor.

• Physicians should record the presence or absence of residual disease, if residual disease is observed, the size of the largest visible lesion should be documented